Skip to main content
Equibles
PGEN logo

PGEN · Precigen, Inc.

Track PGEN — free

Use PGEN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PGEN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.10 -0.39 (-6.01%) At close · Aug 14
Customer concentration — top 4 customers 49.9% of revenue

4 customers — 49.9% of revenue (the three months ended March 31, 2025)

“For the three months ended March 31, 2025, four customers accounted for 49.9% of total condensed consolidated revenues.”
View the 10-Q filed May 13, 2026
Market Cap
$2.18B
Shares
358.04M

Precigen, Inc. Earnings Call Transcripts

Every quarterly earnings call for Precigen, Inc. (PGEN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲13.7% $19.33M −$41.66M '20 Q4 21-03-01 ▼87.5% $3.81M −$20.05M '21 Q2 21-08-09 ▼85.9% $3.33M −$29.76M '21 Q3 21-11-04 ▼23.7% $2.91M −$17.64M '22 Q2 22-08-08 ▲401.7% $16.72M $87.38M '22 Q3 22-11-09 · $1.76M −$22.18M '22 Q4 23-01-24 ▼66.4% $1.85M −$22.73M '23 Q1 23-05-10 ▼39.3% $1.77M −$20.32M '23 Q2 23-08-09 · $1.34M −$54.15M '25 Q1 25-05-14 ▲1633.9% $23.25M −$7.93M '26 Q1 26-05-13 LATEST ▲6322.7% $54.98M $20.07M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
Precigen, Inc. Q2 FY2026 Earnings Call
Revenue
$54.98M
▲ 6322.7% YoY
Diluted EPS
$0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Precigen, Inc. Q1 FY2026 Earnings Call
Confident tone PAPZIMEOS launch trajectory ASCO durability data and label expansion Payer coverage and access
Revenue
$23.25M
▲ 1633.9% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Precigen, Inc. Q4 FY2025 Earnings Call
Confident tone RRP disease and standard of care Patient and prescriber adoption Payer coverage and reimbursement
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Precigen, Inc. Q3 FY2025 Earnings Call
Confident tone Papcemias approval and clinical profile Geographic expansion Redosing and label expansion
Diluted EPS
$-1.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Precigen, Inc. Q1 FY2025 Earnings Call
Revenue
$1.34M
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Precigen, Inc. Q2 FY2024 Earnings Call
Confident tone PRGN-2012 lead asset for RRP Commercial launch preparation Confirmatory trial and regulatory path
Diluted EPS
$-0.23
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Precigen, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-19
Precigen, Inc. Q4 FY2023 Earnings Call
Confident tone PRGN-2012 lead asset / RRP Commercial readiness and launch planning Phase 2 data and regulatory pathway
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-08-09
Precigen, Inc. Q2 FY2023 Earnings Call
Revenue
$1.77M
▼ 39.3% YoY
Diluted EPS
$-0.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Precigen, Inc. Q1 FY2023 Earnings Call
Revenue
$1.85M
▼ 66.4% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-24
Precigen, Inc. Q4 FY2022 Earnings Call
Revenue
$1.76M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Precigen, Inc. Q3 FY2022 Earnings Call
Revenue
$16.72M
▲ 401.7% YoY
Diluted EPS
$0.44
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Precigen, Inc. Q2 FY2022 Earnings Call
Revenue
$2.91M
▼ 23.7% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-11-04
Precigen, Inc. Q3 FY2021 Earnings Call
Revenue
$3.33M
▼ 85.9% YoY
Diluted EPS
$-0.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Precigen, Inc. Q2 FY2021 Earnings Call
Revenue
$3.81M
▼ 87.5% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Precigen, Inc. Q4 FY2020 Earnings Call
Revenue
$19.33M
▲ 13.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Precigen, Inc. Q3 FY2020 Earnings Call
Revenue
$23.58M
▲ 28.9% YoY
Diluted EPS
$-0.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Precigen, Inc. Q2 FY2020 Earnings Call
Revenue
$30.42M
▼ 7.3% YoY
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Precigen, Inc. Q1 FY2020 Earnings Call
Revenue
$29.84M
▲ 32.1% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-02
Precigen, Inc. Q4 FY2019 Earnings Call
Revenue
$17.00M
▼ 58.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–20 of 20 earnings calls
Key facts CIK 1356090 CUSIP 74017N105 13F (30d) 202 filings 199 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)